CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to RHHBY

Bevacizumab 15 mg/kg

Phase 2
Roche Holding AG (RHHBY)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q3 '27
RHHBYPhase 2

Atezolizumab Phase 2 Est. Readout

Bevacizumab 15 mg/kg
Q3 2027~Q
CT.gov
00%
Competitive Landscape

0 competitors in Advanced Liver Cancers

View Full Landscape
Drug Information

Target Indication

Advanced Liver Cancers

Clinical Trial

NCT04524871

Last updated: 1/6/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.